1

Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

yvfppoqo6dbr
Background: Care gaps remain in modern health care despite the availability of robust. evidence-based medications. Although sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated profound benefits in improving both cardiovascular and kidney outcomes in patients. the uptake of these medications remain suboptimal. https://miabellesbabyes.shop/product-category/girls-spring-top/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story